Stocks · Korea 200130 KOSDAQ

KolmarBNH

8,170원 +1.24% Market cap 2,351억 2026-10-07 close
Data as of 2026-10-07 · Linked from 7 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR0.65x
EPS0 KRW
BPS12,503 KRW
ROE-0.46%
DPS75 KRW

Returns and 52-week range

1W+4.48%
1M-7.16%
3M-3.31%
6M-29.51%
1Y-48.13%
YTD-37.82%
52W high15,950원
52W low7,600원
From 52W high-48.78%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20225,759억611억404억10.6%
20235,796억303억187억5.2%
20246,156억246억172억4.0%
20255,749억266억-226억4.6%
Quarterly
2024 4Q1,421억32억21억2.3%
2025 1Q1,367억36억14억2.6%
2025 2Q1,641억107억67억6.5%
2025 3Q1,518억97억62억6.4%
2025 4Q1,222억26억-370억2.2%
2026 1Q1,369억103억224억7.5%

Company

CEO이승화
Founded2014-04-22
Fiscal year end12
Address: 세종특별자치시 전의면 산단길 22-15 콜마비앤에이치(주)

Peers in the same sector

CompanyMarket capP/EP/B1M
바이오플러스2,385억15.301.36+17.27%
휴온스2,323억5.310.60-7.45%
현대약품2,614억85.102.60+6.64%
대화제약2,258억129.042.93+14.43%
삼진제약2,640억10.100.86+5.31%
한국비엔씨2,247억78.210.96+25.38%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.